Literature DB >> 16124935

Physicians' prescribing of anti-hypertensive combinations in a tertiary care setting in southwestern Nigeria.

Kazeem B Yusuff1, Olumide Balogun.   

Abstract

PURPOSE: To evaluate physicians' prescribing of anti-hypertensive drug combinations in a tertiary care setting in southwestern Nigeria, determine the degree of usage of Angiotensin Converting Enzyme (ACE) inhibitor-based combinations and identify specific points of intervention to improve outcomes of anti-hypertensive combination therapy.
METHODS: A cross-sectional retrospective drug use review was conducted between June 1st and August 31st 2002 using randomly selected 200 case notes of patients attending the Hypertension Clinic at a 900-bed tertiary care facility in southwestern Nigeria. 11 case notes were not used due to incompleteness.
RESULTS: 73% (138) of the patients were on anti-hypertensive drug combinations, comprising 71.7% (99), 24.4% (34) and 3.6% (5) on combinations of two, three and four drugs respectively. Overall, Thiazide diuretic consisting mainly of fixed dose combination of Amiloride and Hydorchlorothiazide (Moduretic(r)) was the most frequently prescribed drug class in anti-hypertensive combination therapy (83.3%). ACE inhibitor, Lisinopril (Zestril(r)), was prescribed in combination with Moduretic(r), Calcium channel blocker and beta-blocker in 6.5%, 8.5% and 0.7% respectively. Blood pressure control was adequate in only 29% (40) of patients, though adherence with therapy was documented as adequate in 77.5% (107). Type-2 diabetes mellitus (32.7%) and osteoarthritis (21.8%) were the most frequent co-morbidities. Potentially harmful drug-drug interactions in the study sample were identified in 17.5% (46) of patients. Physician documentation of adverse drug reactions among patients was done in only 10.9% of cases. There appear to be no institutionalised system in place to monitor, detect and document adverse drug reactions among patients on anti-hypertensive drug therapy.
CONCLUSION: Physicians' prescribing of anti-hypertensive drug combinations in a tertiary care setting in southwestern Nigeria is considerable. However, this practice does not appear to have positively impacted on blood pressure control among hypertensive patients nor being modulated by an Institutionalised standard guide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16124935

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  8 in total

1.  Effects of aerobic exercise and drug therapy on blood pressure and antihypertensive drugs: a randomized controlled trial.

Authors:  F A Maruf; A O Akinpelu; B L Salako
Journal:  Afr Health Sci       Date:  2013-03       Impact factor: 0.927

2.  TREATMENT RESPONSE IN ADULT PATIENTS WITH HYPERTENSION ATTENDING A SECONDARY HEALTH CARE CENTER IN SOUTH-WEST NIGERIA.

Authors:  I A Azeez; M D Dairo; J O Akinyemi
Journal:  Ann Ib Postgrad Med       Date:  2019-12

Review 3.  Prevalence of drug interactions in hospital healthcare.

Authors:  María Espinosa-Bosch; Bernardo Santos-Ramos; María Victoria Gil-Navarro; María Dolores Santos-Rubio; Roberto Marín-Gil; Paloma Villacorta-Linaza
Journal:  Int J Clin Pharm       Date:  2012-09-11

4.  A Narrative Synthesis of the Health Systems Factors Influencing Optimal Hypertension Control in Sub-Saharan Africa.

Authors:  Juliet Iwelunmor; Jacob Plange-Rhule; Collins O Airhihenbuwa; Chizoba Ezepue; Olugbenga Ogedegbe
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

5.  Assessment of prescribing, dispensing, and patient use pattern of antihypertensive drugs for patients attending outpatient department of Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia.

Authors:  Fedila Shukrala; Tesfaye Gabriel
Journal:  Drug Des Devel Ther       Date:  2015-01-17       Impact factor: 4.162

6.  Anti-hypertensive medicines prescribing for medical outpatients in a premier teaching hospital in Nigeria: a probable shift of paradigm.

Authors:  Unyime I Eshiet; Kazeem B Yusuff
Journal:  Pharm Pract (Granada)       Date:  2014-03-15

Review 7.  Prevalence, determinants and systems-thinking approaches to optimal hypertension control in West Africa.

Authors:  Juliet Iwelunmor; Collins O Airhihenbuwa; Richard Cooper; Bamidele Tayo; Jacob Plange-Rhule; Richard Adanu; Gbenga Ogedegbe
Journal:  Global Health       Date:  2014-05-21       Impact factor: 4.185

8.  Factors Associated with Medication Nonadherence among Hypertensives in Ghana and Nigeria.

Authors:  Vincent Boima; Adebowale Dele Ademola; Aina Olufemi Odusola; Francis Agyekum; Chibuike Eze Nwafor; Helen Cole; Babatunde L Salako; Gbenga Ogedegbe; Bamidele O Tayo
Journal:  Int J Hypertens       Date:  2015-10-05       Impact factor: 2.420

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.